首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1191608

癌症幹細胞的全球市場調查報告 - 產業分析，規模，佔有率，成長，趨勢，2022年～2028年前的預測

Global Cancer Stem Cell Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

出版日期: 2022年12月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

Value Market Research深入調查癌症幹細胞的全球市場，並預測未來幾年行業將出現顯著增長。本研究報告提供全球癌症幹細胞市場相關之完全產業分析，提供市場規模、市場佔有率、增長趨勢、2023年至2028年的預測等。該報告以詳細的市場介紹和突出報告關鍵增長數據的執行摘要為首。接續的章節討論市場價值鏈、波特五力模型和市場吸引力分析。同時還設立關於COVID-19影響分析的獨立章節，以瞭解市場如何應對疫情。

本報告的市場動態部分詳細介紹了當前的市場推動因素/阻礙、課題/風險和未來機遇。本節對企業戰略家和新產品開發部門非常有用。癌症幹細胞全球市場調查將市場細分化，並根據收益和/或銷售額的視點提供市場規模。該數據地區細分，同時國家/地區細分。數據是通過深入的初級訪談和世界各地的行業專家收集而來。詳細的調查方法可以在樣本報告中找到。這些市場預測受到最新的社會、政治和經濟變化以及影響該癌症幹細胞市場的當前市場動態所影響。

癌症幹細胞市場報告的子章節提供市場競爭力調查，提供一些領先的市場參與者/製造商簡介。這些章節涵括可深入瞭解競爭對手的產品線、財務狀況、最新發展以及在行業中擁有最高市場佔有率公司所需的豐富資訊。

各COVID-19發生影響分析
- 對生產的直接性影響
- 供應鏈與市場的混亂
- 對企業及金融市場的財務性影響
COVID-19生產，進口，出口，各需求的影響分析
市場COVID-19發生前/發生後
冠狀病毒(COVID-19)流行的影響預測
COVID-19:微觀和宏觀的要素分析

第6章癌症幹細胞的全球市場分析:癌症類別

癌症的不同形態概要
實際成果資料及預測資料
癌症的不同形態分析
乳房
血液
肺
腦
大腸
胰臟
膀胱
肝臟
其他

第7章全球癌症幹細胞市場分析:各應用領域

概要:各應用領域
實際成果資料及預測資料
分析:各應用領域
靶向癌幹細胞
幹細胞腫瘤治療

第8章癌症幹細胞的全球市場分析:各地區

各地區展望
簡介
北美的銷售額分析
- 概要，過去和未來的銷售額分析
- 北美各市場區隔銷售額分析
- 北美:各國銷售額分析
- 美國的銷售額分析
- 加拿大的銷售額分析
- 墨西哥的銷售額分析
歐洲的銷售額分析
- 概要，銷售額實際成果與預測分析
- 歐洲的各市場區隔銷售額分析
- 歐洲:各國銷售額分析
- 英國的銷售額分析
- 法國的銷售額分析
- 德國的銷售額分析
- 義大利的銷售額分析
- 俄羅斯的銷售額分析
- 其他歐洲的銷售額分析
亞太地區的銷售額分析
- 概要，銷售額實際成果與預測分析
- 亞太地區的各市場區隔銷售額分析
- 亞太地區的各國銷售額分析
- 中國的銷售額分析
- 印度的銷售額分析
- 日本的銷售額分析
- 韓國的銷售額分析
- 澳洲的銷售額分析
- 其他亞太地區的銷售額分析
南美的銷售額分析
- 概要，銷售額實際成果與預測分析
- 南美的各市場區隔銷售額分析
- 南美:各國銷售額分析
- 巴西的銷售額分析
- 阿根廷的銷售額分析
- 秘魯的銷售額分析
- 智利的銷售額分析
- 其他南美國家的銷售額分析
中東·非洲的銷售額分析
- 概要，銷售額實際成果與預測分析
- 中東·非洲地區各市場區隔銷售額分析
- 中東·非洲各國銷售額分析
- 沙烏地阿拉伯的銷售額分析
- UAE的銷售額分析
- 以色列的銷售額分析
- 南非的銷售額分析
- 其他中東·非洲地區的銷售額分析

第9章癌症幹細胞企業的競爭情形

癌症幹細胞市場競爭
夥伴關係/合作/協定
合併·收購
新產品的上市
其他的開發

第10章企業簡介

龍頭企業的市場佔有率分析
市場集中度
Fisher Scientific Inc.
- 企業概要
- 企業收益
- 產品介紹
- 最近的開發情形
AbbVie Inc.
- 公司概要
- 企業收益
- 產品資訊
- 最近的開發情形
Miltenyi Biotec
- 公司概要
- 企業收益
- 產品資訊
- 最近的開發情形
Stemcell Technologies Inc.
- 公司概要
- 企業收益
- 產品資訊
- 最近的開發情形
Merck KGaA
- 公司概要
- 企業收益
- 產品資訊
- 最近的開發情形
Stemline Therapeutics Inc.
- 公司概要
- 企業收益
- 產品資訊
- 最近的開發情形
MacroGenics Inc.
- 公司概要
- 企業收益
- 產品資訊
- 最近的開發情形
Bionomics
- 公司概要
- 企業收益
- 產品資訊
- 最近的開發情形
Fujifilm Irvine Scientific.
- 公司概要
- 企業收益
- 產品資訊
- 最近的開發情形
Lineage Cell Therapeutics Inc.
- 公司概要
- 企業收益
- 產品資訊
- 最近的趨勢

在公司簡介中，財務細節和最近的發展基於可取得的現有信息，可能不包含非上市公司。

簡介目錄圖表

Product Code: VMR11219676

Value Market Research deeply researched the Global Cancer Stem Cell Market to foresee a significant growth in the industry over the upcoming years. The global cancer stem cell market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global cancer stem cell market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this cancer stem cell market.

The next sections of the cancer stem cell market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Cancer Forms

Breast

Blood

Lung

Brain

Colorectal

Pancreatic

Bladder

Liver

Others

By Application

Trageted Cancerous Stem Cells

Stem Cell-based cancer Therapy

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CANCER STEM CELL - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Cancer Forms
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL CANCER STEM CELL MARKET ANALYSIS BY CANCER FORMS

6.1 Overview by Cancer Forms
6.2 Historical and Forecast Data
6.3 Analysis by Cancer Forms
6.4 Breast Historic and Forecast Sales by Regions
6.5 Blood Historic and Forecast Sales by Regions
6.6 Lung Historic and Forecast Sales by Regions
6.7 Brain Historic and Forecast Sales by Regions
6.8 Colorectal Historic and Forecast Sales by Regions
6.9 Pancreatic Historic and Forecast Sales by Regions
6.10. Bladder Historic and Forecast Sales by Regions
6.11 Liver Historic and Forecast Sales by Regions
6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL CANCER STEM CELL MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Trageted Cancerous Stem Cells Historic and Forecast Sales by Regions
7.5 Stem Cell-based cancer Therapy Historic and Forecast Sales by Regions

8 . GLOBAL CANCER STEM CELL MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CANCER STEM CELL COMPANIES

9.1. Cancer Stem Cell Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CANCER STEM CELL INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Fisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. AbbVie Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Miltenyi Biotec
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Stemcell Technologies Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Merck KGaA
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Stemline Therapeutics Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. MacroGenics Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Bionomics
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Fujifilm Irvine Scientific.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Lineage Cell Therapeutics Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表